Chandra Bhagat Pharma Limited (BOM:542934)
India
· Delayed Price · Currency is INR 36.58
-1.92 (-4.99%)
At close: Mar 9, 2026
Chandra Bhagat Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2017 |
| Market Capitalization | 276 | 395 | 717 | 732 | 859 | 299 | Upgrade
|
| Market Cap Growth | -72.29% | -44.92% | -2.06% | -14.76% | 187.37% | -1.00% | Upgrade
|
| Enterprise Value | 461 | 593 | 882 | 926 | 1,079 | 538 | Upgrade
|
| Last Close Price | 36.58 | 52.33 | 95.00 | 97.00 | 113.80 | 39.60 | Upgrade
|
| PE Ratio | 44.25 | 46.03 | 46.84 | 80.83 | 107.77 | 157.34 | Upgrade
|
| PS Ratio | 0.56 | 0.45 | 0.32 | 0.61 | 0.91 | 0.42 | Upgrade
|
| PB Ratio | 0.91 | 1.32 | 2.47 | 2.66 | 3.22 | 1.16 | Upgrade
|
| P/TBV Ratio | 0.91 | 1.32 | 2.47 | 2.66 | 3.22 | 1.16 | Upgrade
|
| P/FCF Ratio | 19.23 | - | 18.41 | 14.95 | 6.98 | 3.60 | Upgrade
|
| P/OCF Ratio | 10.35 | - | 11.61 | 13.90 | 6.93 | 3.59 | Upgrade
|
| EV/Sales Ratio | 0.93 | 0.67 | 0.40 | 0.77 | 1.15 | 0.76 | Upgrade
|
| EV/EBITDA Ratio | 14.24 | 19.08 | 24.14 | 24.51 | 20.93 | 12.08 | Upgrade
|
| EV/EBIT Ratio | 21.37 | 26.65 | 27.85 | 25.25 | 21.09 | 12.18 | Upgrade
|
| EV/FCF Ratio | 32.15 | - | 22.66 | 18.91 | 8.77 | 6.48 | Upgrade
|
| Debt / Equity Ratio | 0.69 | 0.70 | 0.57 | 0.69 | 0.79 | 1.05 | Upgrade
|
| Debt / EBITDA Ratio | 6.52 | 6.72 | 4.49 | 5.02 | 4.10 | 6.08 | Upgrade
|
| Debt / FCF Ratio | 14.71 | - | 4.22 | 3.87 | 1.72 | 3.26 | Upgrade
|
| Net Debt / Equity Ratio | 0.61 | 0.67 | 0.39 | 0.45 | 0.57 | 0.94 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.72 | 6.46 | 3.10 | 3.28 | 2.95 | 5.44 | Upgrade
|
| Net Debt / FCF Ratio | 12.92 | -2.96 | 2.91 | 2.53 | 1.24 | 2.92 | Upgrade
|
| Asset Turnover | 0.54 | 0.87 | 2.74 | 1.80 | 1.30 | 0.97 | Upgrade
|
| Inventory Turnover | 19.27 | 15.69 | 11.03 | 3.38 | 2.35 | 1.51 | Upgrade
|
| Quick Ratio | 0.57 | 0.53 | 0.63 | 0.55 | 0.55 | 0.56 | Upgrade
|
| Current Ratio | 1.49 | 1.41 | 1.38 | 2.16 | 1.86 | 2.13 | Upgrade
|
| Return on Equity (ROE) | 2.07% | 2.91% | 5.42% | 3.34% | 3.03% | 0.74% | Upgrade
|
| Return on Assets (ROA) | 1.48% | 1.37% | 2.44% | 3.44% | 4.43% | 3.77% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.34% | 3.52% | 4.73% | 5.75% | 8.02% | 4.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.90% | 6.90% | 10.30% | 10.90% | 14.90% | 11.40% | Upgrade
|
| Earnings Yield | 2.25% | 2.17% | 2.14% | 1.24% | 0.93% | 0.64% | Upgrade
|
| FCF Yield | 5.20% | -17.18% | 5.43% | 6.69% | 14.32% | 27.81% | Upgrade
|
| Buyback Yield / Dilution | 0.06% | - | - | - | - | -31.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.